{"schema_version":"1","generated_at":"2026-11-02T14:16:04.864Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/luke-pater","json_url":"https://www.findmykol.com/kol/luke-pater/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"luke-pater","name":"Luke Pater","credential":"MD","title":"Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati)","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology","Sarcoma"],"institution":"University of Cincinnati","institution_url":"https://www.findmykol.com/institution/university-of-cincinnati","city":"Cincinnati","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1386769461","orcid":"0000-0001-8297-8464","openalex":"A5024010972"},"summary":"Luke Pater is Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati) at University of Cincinnati. OpenAlex indexes 74 publications with 1,646 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.","overview":{"text":"Luke Pater, MD, is Professor of Clinical, Radiation Oncology, College of Medicine (University of Cincinnati). The public record shows 74 publications with 1,646 citations (h-index 16), centered on Glioma Diagnosis and Treatment, Radiation Therapy and Dosimetry, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 1 companies.","bullets":["Top research focus: Glioma Diagnosis and Treatment","2 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-11-02"},"focus":{"indications":[{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Diffuse Intrinsic Pontine Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":1,"strength":1}],"research_topics":["Glioma Diagnosis and Treatment","Radiation Therapy and Dosimetry","Sarcoma Diagnosis and Treatment","Advanced Radiotherapy Techniques","Meningioma and schwannoma management"],"works_with":{"total":3,"shown":3,"withheld":0,"rows":[{"name":"GT Medical Technologies, Inc","trials":0,"payments":1,"mentions":1},{"name":"Proton Collaborative Group","trials":1,"payments":0,"mentions":1},{"name":"University of Cincinnati","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":74,"cited_by_count":1646,"h_index":16,"i10_index":22,"pubmed_count":0,"latest_activity_year":2022,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT03841435","title":"Hypofractionated Radiotherapy for Recurrent DIPG","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"University of Cincinnati","source_url":"https://clinicaltrials.gov/study/NCT03841435","trial_url":"https://www.findmykol.com/trial/NCT03841435"},{"nct":"NCT01255748","title":"Registry Study for Radiation Therapy Outcomes","status":"RECRUITING","role":"Investigator","sponsor":"Proton Collaborative Group","source_url":"https://clinicaltrials.gov/study/NCT01255748","trial_url":"https://www.findmykol.com/trial/NCT01255748"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2022,"last":2022},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"GT Medical Technologies, Inc","program_year":2022,"amount_usd":159.78,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1386769461"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1386769461","source":"payments"},"prescribing":{"data_year":2019,"areas_total":1,"areas_shown":1,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2019,"office_pct":89,"facility_pct":11},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":17,"years":{"first":2014,"last":2026},"societies":["ASCO","ASTRO"],"shown":3,"withheld":14,"rows":[{"title":"An Institutional Experience of Radiotherapy for Sialorrhea in Patients with Amyotrophic Lateral Sclerosis","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2026.06.1512","source_url":"https://doi.org/10.1016/j.ijrobp.2026.06.1512","status":"verified"},{"title":"Multi-Institutional Analysis of Dose and Factors Associated with All Cause Morbidity after Stereotactic Radiotherapy for Intact Melanoma Brain Metastases","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2026.06.881","source_url":"https://doi.org/10.1016/j.ijrobp.2026.06.881","status":"verified"},{"title":"Superficial Hypofractionated Radiation Therapy for Nonmelanoma Skin Cancer (NMSC): Comparable Outcomes across Fractionation Schedules","society":"ASTRO","meeting":"ASTRO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1016/j.ijrobp.2026.06.2238","source_url":"https://doi.org/10.1016/j.ijrobp.2026.06.2238","status":"verified"}],"source":"congress"},"publications":{"total":0,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma","year":2026,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/1545-5017.70305","status":"verified"},{"title":"Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis","year":2026,"journal":"Journal of Neuro-Oncology","source_url":"https://doi.org/10.1007/s11060-026-05450-5","status":"verified"},{"title":"Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials","year":2025,"journal":"Nature Reviews Urology","source_url":"https://doi.org/10.1038/s41585-025-01055-1","status":"verified"},{"title":"AREN1721, a randomized phase 2 trial of axitinib+nivolumab combination therapy vs. single agent nivolumab for the treatment of TFE/translocation renal cell carcinoma (tRCC) across all age groups, an NCI National Clinical Trials Network (NCTN) phase 2 study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.4521","status":"verified"},{"title":"Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives","year":2025,"journal":"Pediatric Blood & Cancer","source_url":"https://doi.org/10.1002/pbc.31790","status":"verified"}],"most_cited":{"total":74,"shown":5,"withheld":69,"rows":[{"title":"Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human","year":2003,"cited_by_count":478,"type":"article","source_url":"https://doi.org/10.1172/jci17892"},{"title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy","year":2006,"cited_by_count":360,"type":"article","source_url":"https://doi.org/10.1073/pnas.0510519103"},{"title":"Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy","year":2003,"cited_by_count":122,"type":"article","source_url":"https://doi.org/10.1172/jci16738"},{"title":"Wilms tumor","year":2020,"cited_by_count":84,"type":"review","source_url":"https://doi.org/10.1002/pbc.28257"},{"title":"Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN","year":2018,"cited_by_count":65,"type":"article","source_url":"https://doi.org/10.1016/j.radonc.2018.05.020"}]},"source":"works"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"John C. Breneman","coauthored_works":27},{"name":"Ralph E. Vatner","coauthored_works":13},{"name":"Timothy D. Struve","coauthored_works":10}],"source":"works"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"Board certification: American Board of Radiology (Radiation Oncology), certified 2012-05-22","source_url":"https://med.uc.edu/depart/neuro/directory/faculty-profile/Index/Pubs/paterl","status":"verified","collected_at":"2026-11-02"},{"value":"MD (Medical Degree), University of Cincinnati College of Medicine","source_url":"https://med.uc.edu/depart/neuro/directory/faculty-profile/Index/Pubs/paterl","status":"verified","collected_at":"2026-11-02"},{"value":"Bachelor's degree, Miami University","source_url":"https://med.uc.edu/depart/neuro/directory/faculty-profile/Index/Pubs/paterl","status":"verified","collected_at":"2026-11-02"}]},"secondary_affiliations":{"total":1,"shown":1,"rows":[{"value":"UC Health Barrett Center (UC Health / Barrett Cancer Center)","source_url":"https://ucneuroscience.com/luke-pater","status":"provisional","collected_at":"2026-11-02"}]}},"similar":[{"name":"Alberto Espay","slug":"alberto-espay","institution":"University of Cincinnati","specialty":"Neurology","url":"https://www.findmykol.com/kol/alberto-espay","json_url":"https://www.findmykol.com/kol/alberto-espay/profile.json"},{"name":"Davendra Sohal","slug":"davendra-sohal","institution":"University of Cincinnati","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/davendra-sohal","json_url":"https://www.findmykol.com/kol/davendra-sohal/profile.json"},{"name":"Punam Malik","slug":"punam-malik","institution":"University of Cincinnati","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/punam-malik","json_url":"https://www.findmykol.com/kol/punam-malik/profile.json"},{"name":"Michael Luggen","slug":"michael-luggen","institution":"University of Cincinnati","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michael-luggen","json_url":"https://www.findmykol.com/kol/michael-luggen/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":14,"publications":45,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-02"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-02"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2022","collected_at":"2026-11-02"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-02"}},"methodology_url":"https://www.findmykol.com/about#methodology"}